Safety of Arthritis Drugs, Day 3. Part 4
This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …
140 viewsThis is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …
140 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…
237 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …
290 viewsThe Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…
501 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues in…
219 views